Guillaume Meric

Mar 24, 2024 | nature.com | Yang Liu |Scott Ritchie |Karin Verspoor |Veikko Salomaa |Aki S Havulinna |Guillaume Meric

AbstractMultiomics has shown promise in noninvasive risk profiling and early detection of various common diseases. In the present study, in a prospective population-based cohort with ~18 years of e-health record follow-up, we investigated the incremental and combined value of genomic and gut metagenomic risk assessment compared with conventional risk factors for predicting incident coronary artery disease (CAD), type 2 diabetes (T2D), Alzheimer disease and prostate cancer.